Sentence examples for we demonstrated proof from inspiring English sources
We demonstrated proof of concept for the three sensing architectures by measuring the detected signal due to the passage of micron-sized beads through the pore.
Altogether, we demonstrated proof-of-concept evidence for the feasibility, capability and safety of a nanovaccine platform towards efficient personalized anticancer application.
Therefore, we demonstrated proof-of-principle that concentrating a target virus with ATPS prior to the detection step enhances the detection limit of the LFA, thereby increasing the sensitivity of the immunoassay.
We demonstrate proof of concept that ETI motions can be recorded by portable IMUs.
We demonstrate proof of principle for this approach by identifying two peptides that were both specific for cancer cells but internalized via different mechanisms of endocytosis.
We demonstrate proof of principle of multiple transcript profiling in archival diagnostic biopsies of non-surgically treated men for biomarker discovery.
We demonstrate proof of principle using a retrospective study investigating malignant pleural mesothelioma (MPM) patient tumour measurements in patients treated with either of two analogous chemotherapy regimens.
16, 17 Herein, we demonstrate proof of principle for the fragmenting hybrid approach by demonstrating the successful release of the potent and irreversible DPAP1 inhibitor ML4118S 15 from fragmenting hybrid 8.
While combinatorial therapies have been used extensively to control carcinoma [ 17], in this study we demonstrate proof of concept for the use of Sirolimus and Nimotuzumab as combination therapy.
In this study, we demonstrate proof of concept that Nimotuzumab and rapamycin is effective as a combination therapy in glioma cell lines derived from Caucasian and Asian glioma patients.
We demonstrate proof-of-principle by using the gene-based test to replicate several genes known to be associated on the basis of results from a family-based GWAS for height in 11,536 individuals and a DNA-pooling-based GWAS for melanoma in ∼1300 cases and controls.
